Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
Journal of Medicinal Chemistry · 28.09.2023 · 66 (18) · 12651-12677
DOI: 10.1021/acs.jmedchem.2c01737 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.09.2023. Verfasst von Arash Sadri. Beteiligte Einrichtung: Lyceum Scientific Charity, Tehran, Iran, 1415893697. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 442 Literaturangaben.
Abstract (Originalsprache)
Target-based drug discovery is the dominant paradigm of drug discovery; however, a comprehensive evaluation of its real-world efficiency is lacking. Here, a manual systematic review of about 32000 articles and patents dating back to 150 years ago demonstrates its apparent inefficiency. Analyzing the origins of all approved drugs reveals that, despite several decades of dominance, only 9.4% of small-molecule drugs have been discovered through "target-based" assays. Moreover, the therapeutic effects of even this minimal share cannot be solely attributed and reduced to their purported targets, as they depend on numerous off-target mechanisms unconsciously incorporated by phenotypic observations. The data suggest that reductionist target-based drug discovery may be a cause of the productivity crisis in drug discovery. An evidence-based approach to enhance efficiency seems to be prioritizing, in selecting and optimizing molecules, higher-level phenotypic observations that are closer to the sought-after therapeutic effects using tools like artificial intelligence and machine learning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Lyceum Scientific Charity, Tehran, Iran, 1415893697.
- Interdisciplinary Neuroscience Research Program (INRP), Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran, 1417755331.
- Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran, 1417614411.
ORCID-Profile: Arash Sadri
Zitieren
APA
Sadri, A. (2023). Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs. Journal of Medicinal Chemistry, 66(18), 12651-12677. https://doi.org/10.1021/acs.jmedchem.2c01737
Vancouver
Sadri A. Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs. Journal of Medicinal Chemistry. 2023;66(18):12651-12677. doi:10.1021/acs.jmedchem.2c01737
BibTeX
@article{Sadri2023,
author = {Sadri, Arash},
title = {Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {18},
pages = {12651--12677},
doi = {10.1021/acs.jmedchem.2c01737}
}
EUVIMED